Sellar RS - Search Results

1

Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.

Sellar RS, Rowntree C, Vora AJ, Furness CL, Goulden N, Mitchell C, Moorman AV, Hough R. Sellar RS, et al. Br J Haematol. 2018 May;181(4):515-522. doi: 10.1111/bjh.15208. Epub 2018 Apr 24. Br J Haematol. 2018. PMID: 29687881 Free article.

2

Transplants for the old but not for the young?--The enigma of adult ALL.

Sellar RS, Goldstone AH. Sellar RS, et al. Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S71-5. doi: 10.1016/j.bbmt.2010.11.015. Biol Blood Marrow Transplant. 2011. PMID: 21195314 Free article. Review. No abstract available.

3

PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways.

Meja K, Stengel C, Sellar R, Huszar D, Davies BR, Gale RE, Linch DC, Khwaja A. Meja K, et al. Br J Haematol. 2014 Oct;167(1):69-79. doi: 10.1111/bjh.13013. Epub 2014 Jun 30. Br J Haematol. 2014. PMID: 24975213 Free article.

4

Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.

Sellar RS, Gale RE, Khwaja A, Garbowski M, Loddo M, Stoeber K, Williams GH, Linch DC. Sellar RS, et al. Br J Haematol. 2018 May;181(4):486-494. doi: 10.1111/bjh.15211. Epub 2018 Apr 20. Br J Haematol. 2018. PMID: 29676467 Free article.

5

Redefining transplant in acute leukemia.

Sellar R, Goldstone AH, Lazarus HM. Sellar R, et al. Curr Treat Options Oncol. 2011 Dec;12(4):312-28. doi: 10.1007/s11864-011-0166-0. Curr Treat Options Oncol. 2011. PMID: 21956640

6

Management of multidrug-resistant viruses in the immunocompromised host.

Sellar RS, Peggs KS. Sellar RS, et al. Br J Haematol. 2012 Mar;156(5):559-72. doi: 10.1111/j.1365-2141.2011.08988.x. Epub 2011 Dec 22. Br J Haematol. 2012. PMID: 22188225 Free article. Review.

7

BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients.

Sellar RS, Fend F, Akarca AU, Agostinelli C, Shende V, Quintanilla-Martínez L, Stein H, Pileri SA, Linch D, Marafioti T. Sellar RS, et al. Br J Haematol. 2015 Jul;170(2):282-5. doi: 10.1111/bjh.13291. Epub 2015 Mar 10. Br J Haematol. 2015. PMID: 25758903 Free article. No abstract available.

8

Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment.

Sellar RS, Fraser L, Khwaja A, Gale RE, Marafioti T, Akarca A, Hubank M, Brooks T, Stoeber K, Williams G, Linch DC. Sellar RS, et al. Br J Haematol. 2016 Jul;174(2):275-9. doi: 10.1111/bjh.14055. Epub 2016 Apr 8. Br J Haematol. 2016. PMID: 27061724 Free article.

9

Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.

Sellar RS, Mehra V, Fox TA, Grigg A, Kulasekararaj A, Sarma A, de Lavallade H, McLornan D, Raj K, Mufti GJ, Pagliuca A, Mackinnon S, Chakraverty R, Fielding AK, Carpenter B, Kottaridis PD, Khwaja A, Peggs KS, Thomson KJ, Morris EC, Potter VT. Sellar RS, et al. Br J Haematol. 2019 Oct;187(1):e20-e24. doi: 10.1111/bjh.16136. Epub 2019 Aug 8. Br J Haematol. 2019. PMID: 31396948 Free article. No abstract available.

10

Treatment for lymph node tuberculosis.

Sellar RS, Corbett EL, D'Sa S, Linch DC, Ardeshna KM. Sellar RS, et al. BMJ. 2010 Mar 10;340:c63. doi: 10.1136/bmj.c63. BMJ. 2010. PMID: 20219818 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters